Editorial: Emerging receptors as new targets in health and disease

Julie Dam; Julien Hanson; Martyna Szpakowska

doi:10.3389/fendo.2022.1073794

Editorial: Emerging receptors as new targets in health and disease

Front Endocrinol (Lausanne). 2022 Nov 16:13:1073794. doi: 10.3389/fendo.2022.1073794. eCollection 2022.

Authors

Julie Dam¹, Julien Hanson^{2

3}, Martyna Szpakowska⁴

Affiliations

¹ Institut Cochin, Inserm U1016, CNRS UMR 8104, Université Paris Cité, Paris, France.
² Laboratory of Molecular Pharmacology, GIGA-Molecular Biology of Diseases, University of Liège, Liège, Belgium.
³ Laboratory of Medicinal Chemistry, Centre for Interdisciplinary Research on Medicines (CIRM), University of Liège, Liège, Belgium.
⁴ Immunopharmacology and Interactomics, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.

No abstract available

Keywords: ACKR3; angiotensin receptor; atypical receptors; bradykinin receptor; cardiovascular diseases; elastin receptor complex; mineralocorticoid receptor.

Publication types

Editorial